Status | Study |
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition: Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Date: 2008-07-19 Interventions: Biological: Cixutumumab Given |
Completed |
Study Name: AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Condition: Adult Fibrosarcoma Adult Leiomyosarcoma Date: 2008-04-15 Interventions: Drug: saracatinib Given orally Other Name: AZD0530 |
Completed |
Study Name: Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Condition: Osteosarcoma Ewing Sarcoma Family Tumors Malignant Fibrous Date: 2007-07-16 Interventions: Biological: REOLYSIN® REOLYSIN® is given intravenously at a dose of 3x10E10 TCID50 over 60 min |
Completed |
Study Name: Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Condition: Liposarcoma Leiomyosarcoma Fibrosarc Date: 2006-11-15 Interventions: Drug: Sunitinib Malate (SU011248) For each 6 week cycle, patients will take SU011248 every day in the mo |
Completed |
Study Name: Bevacizumab and Radiation Therapy for Sarcomas Condition: Soft Tissue Sarcoma Fibrous Histiocytoma Liposarcoma Date: 2006-07-21 Interventions: Drug: Bevacizumab Bevacizumab |
Completed |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition: Adult Alveolar Soft-part Sarcoma Adult Angiosarcoma Adult Date: 2006-06-28 Interventions: Drug: doxorubicin hydrochloride |
Completed |
Study Name: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans Condition: Dermatofibrosarcoma Protuberans Date: 2005-10-20 Interventions: Drug: imatinib mesylate 400 mg orally twice a day for 10 - 14 days |
Completed |
Study Name: Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans Condition: Soft Tissue Neoplasms Date: 2005-09-12 |
Completed |
Study Name: Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers Condition: Wilms Tumor Fibrosarcoma Carc Date: 2005-08-31 Interventions: Procedure: Myeloablative Chemotherapy |
Completed |
Study Name: Imatinib in Dermatofibrosarcoma Protuberans (DFSP) Condition: Dermatofibrosarcoma Date: 2005-07-20 Interventions: Drug: Imatinib (Glivec) |